Effects of losartan on the collagen degradative enzymes in hypertrophic and congestive types of cardiomyopathic hamsters

被引:21
作者
Masutomo, K
Makino, N
Fushiki, MSMS
机构
[1] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Div Mol & Clin Gerontol, Beppu, Oita 8740838, Japan
[2] Kyoto Prefectural Univ Med, Res Inst Neurol Dis & Geriatr, Dept Pathol & Appl Neurobiol, Kyoto, Japan
关键词
losartan; cardiomyopathy; Syrian hamster; angiotensin II receptor; matrix metalloproteinase;
D O I
10.1023/A:1011942824139
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The present study was undertaken to determine the effects of AT1 receptor blockade which occurred in response to losartan, on the extracellular matrix (ECM) degradation process in the Bio 14.6 (n = 12) and Bio 53.58 (n = 12) strains which are referred as models of hypertrophic and dilated cardiomyopathy, respectively. The administration of losartan (30 mg/kg/day) in hamsters from 10-20 weeks of age reduced the accumulation of the left ventricular collagen matrix in both of the Bio 14.6 and the Bio 53.58 strains. According to the RT-PCR, the levels of mRNA for matrix metalloproteinase (MMP) and the tissue inhibitor of MMP (TIMP) were examined. MMP-1, -2, -3, and -9 were more enhanced in both myopathic strains than in the control F1 beta strains. With losartan, the levels of MMP-1, -2, -9, TIMP-1 and -2 decreased in the both strains but those for MMP-3 did not in Bio 14.6 strains. TIMP-3 and -4 mRNA levels did not change in any of the experimental hamsters, whether treated or untreated with losartan. The Western blots also showed similar observations in the both strains as seen in mRNA expressions although MMP-2 in the Bio 53.58 strains did not differ between treated and untreated with losartan. Although losartan has an inhibitory effect on collagen accumulation in the development of cardiomyopathy, MMPs (-1, -2, -9) and TIMPs (-1, -2) seem to be susceptible to responding to losartan in Bio cardiomyopathic hamsters.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 31 条
[1]   Regulation of human interstitial collagenase (matrix metalloproteinase-1) promoter activity by fibroblast growth factor [J].
Aho, S ;
Rouda, S ;
Kennedy, SH ;
Qin, HP ;
Tan, EML .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 247 (02) :503-510
[2]   SPONTANEOUS HEREDITARY MYOCARDIAL DEGENERATION AND CONGESTIVE HEART FAILURE IN A STRAIN OF SYRIAN HAMSTERS [J].
BAJUSZ, E ;
BAKER, JR ;
NIXON, CW ;
HOMBURGER, F .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1969, 156 (A1) :105-+
[3]   Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro - TIMP-3 promotes apoptosis [J].
Baker, AH ;
Zaltsman, AB ;
George, SJ ;
Newby, AC .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (06) :1478-1487
[4]   IDENTIFICATION AND CHARACTERIZATION OF THE RABBIT ANGIOTENSIN-II MYOCARDIAL RECEPTOR [J].
BAKER, KM ;
CAMPANILE, CP ;
TRACHTE, GJ ;
PEACH, MJ .
CIRCULATION RESEARCH, 1984, 54 (03) :286-293
[5]   2 IMPROVED AND SIMPLIFIED METHODS FOR SPECTROPHOTOMETRIC DETERMINATION OF HYDROXYPROLINE [J].
BERGMAN, I ;
LOXLEY, R .
ANALYTICAL CHEMISTRY, 1963, 35 (12) :1961-&
[6]   The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure [J].
Brilla, CG ;
Rupp, H ;
Funck, R ;
Maisch, B .
EUROPEAN HEART JOURNAL, 1995, 16 :107-109
[7]  
BRINK AJ, 1992, CARDIOVASC RES, V3, P453
[8]   CELLULAR MECHANISMS OF CAPTOPRIL-INDUCED MATRIX REMODELING IN SYRIAN-HAMSTER CARDIOMYOPATHY [J].
DAVISON, G ;
HALL, CS ;
MILLER, JG ;
SCOTT, M ;
WICKLINE, SA .
CIRCULATION, 1994, 90 (03) :1334-1342
[9]   Cardiac collagen remodeling in the cardiomyopathic Syrian hamster and the effect of Losartan [J].
Dixon, IMC ;
Ju, HS ;
Reid, NL ;
ScammellLaFleur, T ;
Werner, JP ;
Jasmin, G .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (07) :1837-1850
[10]   MATRIX METALLOPROTEINASES AND CARDIOVASCULAR-DISEASE [J].
DOLLERY, CM ;
MCEWAN, JR ;
HENNEY, AM .
CIRCULATION RESEARCH, 1995, 77 (05) :863-868